Qiagen Sees Unusually Large Options Volume (NYSE:QGEN)

Qiagen N.V. (NYSE:QGEN) was the target of unusually large options trading on Monday. Stock investors purchased 7,860 call options on the company. This is an increase of 2,205% compared to the typical volume of 341 call options.

Qiagen Stock Up 0.2%

Shares of Qiagen stock traded up $0.08 during midday trading on Monday, hitting $44.40. The company’s stock had a trading volume of 457,389 shares, compared to its average volume of 1,331,149. The firm has a market capitalization of $9.87 billion, a P/E ratio of 26.26, a PEG ratio of 2.48 and a beta of 0.64. Qiagen has a 1-year low of $37.63 and a 1-year high of $51.88. The company has a quick ratio of 1.35, a current ratio of 1.61 and a debt-to-equity ratio of 0.25. The stock has a 50-day simple moving average of $46.19 and a 200-day simple moving average of $46.58.

Qiagen (NYSE:QGEN) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.58 by $0.03. The firm had revenue of $533.00 million during the quarter, compared to analyst estimates of $525.68 million. Qiagen had a return on equity of 14.77% and a net margin of 18.30%.The business’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same period last year, the company posted $0.57 EPS. Qiagen has set its FY 2025 guidance at 2.380-2.380 EPS. Q4 2025 guidance at 0.600-0.600 EPS. As a group, sell-side analysts expect that Qiagen will post 2.26 earnings per share for the current year.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in QGEN. SVB Wealth LLC acquired a new stake in shares of Qiagen during the 1st quarter valued at $31,000. Smartleaf Asset Management LLC raised its stake in shares of Qiagen by 1,383.3% during the 3rd quarter. Smartleaf Asset Management LLC now owns 890 shares of the company’s stock worth $39,000 after purchasing an additional 830 shares in the last quarter. MAI Capital Management lifted its holdings in shares of Qiagen by 998.9% during the 2nd quarter. MAI Capital Management now owns 978 shares of the company’s stock valued at $47,000 after buying an additional 889 shares during the last quarter. Farther Finance Advisors LLC grew its stake in shares of Qiagen by 400.5% in the 2nd quarter. Farther Finance Advisors LLC now owns 1,061 shares of the company’s stock valued at $51,000 after buying an additional 849 shares in the last quarter. Finally, Allworth Financial LP increased its holdings in Qiagen by 260.1% in the second quarter. Allworth Financial LP now owns 1,102 shares of the company’s stock worth $53,000 after buying an additional 796 shares during the last quarter. Institutional investors and hedge funds own 70.00% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently commented on QGEN shares. UBS Group boosted their target price on Qiagen from $48.00 to $50.00 and gave the stock a “neutral” rating in a report on Thursday, August 7th. Weiss Ratings reissued a “hold (c)” rating on shares of Qiagen in a report on Thursday. Cowen reiterated a “hold” rating on shares of Qiagen in a report on Thursday, August 7th. Barclays set a $53.00 price target on shares of Qiagen and gave the stock an “overweight” rating in a research report on Thursday, October 2nd. Finally, Wall Street Zen upgraded Qiagen from a “hold” rating to a “buy” rating in a report on Saturday, November 1st. Three research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat.com, Qiagen presently has an average rating of “Hold” and a consensus target price of $49.69.

About Qiagen

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.